Chapter 2: The Foundation of
The War In Medicine
The Foundation of the War in Medicine
To understand what is going on in medicine we must look to the past. Consider this article from the North Carolina Museum of History on medicine in the 19th century and before:
Now suppose that in the 1830s, which was the peak of the use of leeches, the medical community at the time, plus the leech breeders and scarificator makers got together and decided they had a good thing going. Suppose they said that if they abandoned their techniques for newer techniques that their incomes would drop and many jobs would be lost. Those who grew leeches would make less profits, those who made the scarificators and other instruments would make less profits, the doctors would make less income, and so on. Suppose they all conspired together to suppress all future medical discoveries (made after 1830) in order to maximize their earnings and profits.
Had that happened, we would still be using bloodletting, leeches and scarificators for virtually all diseases. Scientists today would be spending vast amounts of money studying the DNA of the leeches to breed the most efficient leeches. Scientists would be studying the optimum number of leeches to use, and the optimum places on the body to place them for each type of disease. Scientists would be studying the optimum amount of blood to draw. The instrument makers would be designing high precision instruments to make incisions and suctions, and so on and so forth.
The massive dollars they would request from the general public on "research" would yield a very small, but ever-growing amount of progress. A "cure" would always be "just around the corner," but since their interest was in profits and income, not the health, comfort and survival of their patients, the "cure" would never come. They might also figure out ways to cover up the lack of progress in medicine by using creative statistics. They might develop very clever ways to define "cure rates" in order to hide the fact that there was very little progress being made.
What Has Happened
Well, this "what-if" scenario for the 1830s is exactly what happened in modern medicine in the 1920s. Only instead of stopping progress with bloodletting and leeches, the medical profession decided to stop all medical progress at the stage of surgery, chemotherapy, and radiation treatments. The original reason for stopping progress was profits. The pharmaceutical industry, the chemical industry and the petroleum industry (many prescription drugs are made from petroleum products and these three industries had cross-ownership) were afraid that new discoveries might lessen their profits. Using the profits of these industries as bait and influence money, the new mentality spread to the leadership of the medical industry, and from there to many other places.
The stagnation of progress in treating cancer continues today because the enormously profitable procedures of surgery, chemotherapy and radiation make many, many billions of dollars every year for the pharmaceutical industry, the chemical industry, the petroleum industry, medical doctors, hospitals, medical equipment makers, T.V. stations (through the advertising of the pharmaceutical companies), radio stations (ditto), major magazines (ditto), the ACS (the American Cancer Society is basically a public relations vehicle for orthodox medicine), etc. etc.
In other words, the medical community has gone along with the idea that chemotherapy, radiation and surgery are so profitable, that there will never be any progress in the "war against cancer." The leaders have intentionally, willingly, knowingly and pro-actively suppressed every possible advance in cancer treatments for over 80 years, dating back to the 1920s. (Note: Salvarsan, the first chemotherapy drug, was discovered by Nobel Prize winner Paul Ehrlich in 1909 and was initially used primarily on syphilis.)
The Ralph Moss Story, by Ralph Moss
CEOs of top pharmaceutical companies that produced cancer drugs also dominated the Board. They had an obvious vested interest in promoting chemotherapy and undermining natural therapies.
The Chairman and the President of Bristol-Myers Squibb, the world's leading producer of chemotherapy, held high positions on MSKCC's Board.
Of the nine members of the Hospital's powerful Institutional Policy Committee, seven had ties to the pharmaceutical industry
The Hospital itself invested in the stock of these same drug companies.
Directors of the biggest tobacco companies in the U.S., Phillip Morris and RJR Nabisco, held places of honor on the Board.
Six Board Directors also served on the Boards of The New York Times, CBS, Warner Communications, Readers Digest, and other media giants.
Meanwhile, the public's interest in laetrile refused to go away. A lot of people were going across the border to Mexican clinics to get the stuff and my secretary's phone was ringing off the hook with people wanting to know what Sloan-Kettering thought of its value. I was once again told to give out the news that the studies had all been negative.
At home, I called my family together for a meeting. With their support, I decided I couldn't lie on behalf of the Hospital. In November of 1977, I stood up at a press conference and blew the whistle on Memorial Sloan Kettering Cancer Center's suppression of positive results with amygdalin. It felt like jumping off the highest diving board, but I had no doubt I was doing the right thing. I was fired the next day for "failing to carry out his most basic responsibilities" as the Hospital described it to the New York Times. In other words, failing to lie to the American people.
When I tried to pick up my things in my office, I found my files had been padlocked and two armed Hospital guards escorted me from the premises.
Luckily for all of us, I have a very smart wife who all along had been making copies of my research notes and had put a complete extra set of files in a safe place. Those notes turned into my first book, The Cancer Industry, which is still in print (in an updated version) and available in bookstores.
That dramatic day, when I stood up in front of the packed press conference and told the truth, was the beginning of a journey I never could have predicted. I was launched on a mission that I'm still on today - helping cancer patients find the truth about the best cancer treatments.
Well, we weren't able to buy a home until years later, the kids went to colleges on scholarships and loans, and my wife took on a demanding full-time job to help us get by. But in retrospect, my experiences as an insider in "the cancer industry" were among the best things ever to happen to me. My values were put to the test and I had to really examine what was important in my life. It is because of this difficult experience at Sloan-Kettering that I found a truly meaningful direction for my professional life, rather than just climbing Sloan-Kettering's career ladder and losing my soul in the process."
The story of Ralph Moss, which is really the story of Dr. Kanematsu Sugiura, is just the tip of the iceberg. Numerous alternative cancer researchers have been rewarded for their discoveries with jail, being driven out of the country, loss of license, harassment, and many other things. This war is not for the weak at heart.
Copyright (c) 2003 R. Webster Kehr, all rights reserved